C hroniC subdural hematoma (CSDH) is a frequent condition with incidence rates varying from 5.3 to 13.5 cases per 100,000 persons/year in the general population, with a higher incidence among older adults. 5, 9 With aging populations and the increasing use of anticoagulants, higher incidence rates are to be expected. Despite the fact that CSDH is a frequent condition with high rates of retreatment, there is no standardized treatment strategy.
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A CSDH is a slowly growing collection of fluid containing blood and its breakdown products. It can be specified as unilateral (uCSDH) or bilateral (bCSDH). While uCSDHs are seen more frequently, bCSDHs are by no means rare, comprising 16%-24% of observed CSDHs. 2, 3, 8 The majority of clinicians consider bCSDH to be equivalent to uCSDH and employ the same treatment strategies for the two. However, studies have demonstrated that cases of bCSDH are associated with higher rates of retreatment. 12, 14, 15 The clinical presentations of bCSDH have been described as more diverse than unilateral cases, delaying both diagnosis and treatment. 6 In some cases of bCSDH, asymmetrical hematoma volumes or lateralized clinical symptoms are followed by surgical treatment of only the largest or the symptomatic hematoma, leaving the other hematoma untreated. All in all, this suggests that bCSDH should be distinguished from unilateral cases to establish an appropriate surgical treatment strategy.
To date, research on bCSDH has been limited compared with that on uCSDH and has been based on small patient cohorts containing 14-41 patients. 6, 14 Existing studies 13, 16 have identified advanced age (> 75 years), coagulopathy, and use of anticoagulant and/or antiplatelet treatment as risk factors for bCSDH.
In this retrospective analysis of 291 cases of bCSDH in Denmark, we aimed to identify risk factors for retreatment, with a special focus on surgical laterality.
Methods
This work is part of the Danish Chronic Subdural Hematoma Study (DACSUHS), a retrospective multicenter study in which all Danish neurosurgical departments participate: Rigshospitalet University Hospital, Odense University Hospital, Aarhus University Hospital, and Aalborg University Hospital. Patients were identified in the Danish National Patient Register, which contains information on all hospital admittances, with diagnoses and operations recorded according to the International Classification of Diseases, 10th Revision (ICD-10; http://www.who.int/ classifications/icd/en/). The first author (N.C.A.R.) traveled over 10 months (November 1, 2013, to October 31, 2014) to all the neurosurgical departments where she reviewed every single set of medical records and CT scans. Patients with an ICD-10 diagnosis code S065C (CSDH) and a preoperative CT scan showing bCSDH were included in this study.
Clinical and demographic information included age, sex, use of anticoagulant and/or antiplatelet medication, and history of head trauma. A history of head trauma was defined as recognized head trauma within the last 12 months before diagnosis. All patients had their anticoagulation status optimized before surgery, ensuring a preoperative international normalized ratio (INR) between 1 and 2. It was managed in various ways depending on the type of anticoagulant treatment and local guidelines. In some departments surgeons could guide the anticoagulant reversal based on thromboelastography (TEG) and multiplate analysis (platelet function test). Agents used to reverse anticoagulant medications were phytonadione (vitamin K1), thrombocytes, blood plasma, tranexamic acid, prothrombin complex concentrate (Octaplex), and desmopressin analogs.
To qualify the hematoma as chronic, at least 14 days had to have elapsed between head trauma and time of surgery to be included in the study. Patients with ventriculoperitoneal shunts were excluded because of a possible difference in pathogenesis and pathophysiology (15 patients) .
Radiological data were obtained from all preoperative CT scans. The size of each hematoma was calculated using the XYZ/2 method.
17 Total (bilateral) hematoma volume was obtained by adding the volumes assigned to each hematoma. Brain atrophy was estimated as a ratio of the total brain parenchyma to the intracranial diameter between the coronal suture on each side. This ratio was measured on comparable image slices in the axial plane (showing the 2 frontal horns of the lateral ventricles and the septum pellucidum). Hematoma density was classified into 4 groups: homogeneous, mixed, membranous, and separated (as described in Nakaguchi et al.
11
). Surgical information included unilateral or bilateral intervention, surgical procedure, drainage, and surgical complications. No medical adjuncts were used to manage bCSDH. Retreatment (recurrence) was defined as a reaccumulation of the CSDH requiring ipsilateral, contralateral, or bilateral reoperation after discharge from the primary treatment.
Statistical Analysis
Each variable was subjected to univariate analysis to determine its relationship with retreatment. For categorical variables, a chi-square test was employed; for continuous data, a Student t-test or ANOVA test was applied. Those variables showing a relationship stronger than p < 0.25 were subsequently used in a multivariate analysis. A multiple logistic regression model was used to identify independent risk factors among these selected variables. All analysis was performed in the statistical software package R (http://www.r-project.org), and a p value < 0.05 was considered significant.
Ethics
The study was approved by the Danish Data Protection Agency.
Results
A total of 291 patients met the requirements for inclusion in the study. Clinical and radiological data are summarized in Table 1 . Of the 291 patients, 207 (71.1%) were male and 84 (28.9%) were female. Ages ranged from 40 to 98 years, with a mean age of 73.0 years for males and 76.7 years for females. Age distribution had a negative skew of -0.56. Approximately half of the study population (47.8%) received anticoagulant or antiplatelet therapy upon admission. One patient using a novel oral anticoagulant was not treated differently regarding optimization of coagulation status. A history of head trauma was obtained in 155 patients (53.3%). Radiological data of bCSDH showed a mean total hematoma volume of 180.9 cm 3 with an SD ± 69.5 cm 3 , indicating high variation in total hematoma volume.
Surgical data are summarized in Table 1 . A total of 264 patients (90.7%) underwent surgical treatment. Surgical drainage was performed bilaterally in 128 patients (48.5%), whereas 136 patients (51.5%) underwent unilateral drainage. The majority of patients underwent a 1-bur hole craniostomy (92.0%) as opposed to a 2-bur hole craniostomy (2.6%) and craniotomy (5.3%). A closed drainage system with either subgaleal or subdural placement was used in 250 (94.7%) of 264 patients. Postsurgical drainage time varied from 24 to 48 hours. Figure 1 illustrates preoperative hematoma volumes of the right and left side and their relation to surgical intervention. Unilateral surgery was performed in patients having asymmetrical hematoma volumes on each side. The hematoma that underwent surgical drainage was significantly larger than the nonoperated hematoma (p < 0.0001). In those cases that underwent bilateral drainage, there was no significant difference between the hematoma volumes (p = 0.50).
The overall retreatment rate (RR) was 21.6% (57 of 264 surgical patients). The RR for patients receiving bilateral surgery was 14.1% (18 cases), which was significantly lower than the RR in patients receiving unilateral surgery (28.7%; p < 0.004). Retreatment in the unilateral surgery group occurred in 39 cases, on the ipsilateral side (primary operation site) in 16 cases and on the contralateral side (opposite the primary operation site) in 23 cases ( Fig.  2 and Table 2 ). The mean and median times from primary treatment until retreatment were 72.8 and 34 days, respectively. Table 2 shows results from the univariate analysis of the association between retreatment and individual risk factors. We could not demonstrate any significant association between retreatment and sex, age, antiplatelet and/ or anticoagulation therapy, history of head trauma, hematoma size, brain atrophy, surgical procedure type, or surgical complications. Multivariate logistic regression analysis (Table 3) demonstrated that a separated hematoma density (OR 2.56, p = 0.035), no postoperative drainage (OR 4.31, p = 0.020), and unilateral surgery (OR 3.05, p = 0.002) were independent risk factors in the prediction of retreatment, which is in accordance with results on univariate analysis.
In the unilateral surgery group further analysis was performed to investigate the size of the operated hematoma in relation to ipsilateral versus contralateral retreatment. There was no significant difference in hematoma size among the 3 groups: no retreatment, ipsilateral retreatment, and contralateral retreatment. The same analysis was performed on the nonoperated hematoma and, similarly, no significant difference was found (data not shown). Neither was the size of the operated or nonoperated hematoma correlated with the site of retreatment.
The complication rates for unilateral and bilateral surgeries were 8.8% and 13.3%. There was no significant difference in complication rates between the 2 treatment groups (p = 0.25). Infection and acute SDH were the most frequent complications. There were 5 cases of infection in the unilateral group, 2 of which required reoperation, and 3 infections with 1 reoperation in the bilateral group. Reoperations due to complications were performed during primary admission and were not categorized as retreatment. Postoperative seizures were observed in 2 cases in the unilateral group and 4 cases in the bilateral group. Seizures were limited to the postoperative phase; no patients were treated with anticonvulsive medicine after discharge.
Discussion
In this study, the overall retreatment rate of bCSDH was 21.6%, as opposed to 11.5% reported in a recent meta-analysis of 250 studies about primarily uCSDH. 1 Our findings are in accordance with previous data identifying bCSDH as a risk factor for retreatment. 12, 14, 15, 19 We identified unilateral surgery for bCSDH as an independent risk factor for retreatment. Unilateral intervention is often based on hematoma size, which also seemed to be the case in our study (Fig. 1) . Lateralization of symptoms may also affect this decision. Surgeons tend to operate on the larger hematoma or on the more symptomatic side.
Intuitively, one would expect the RR to be twice as high with bilateral drainage since each surgical procedure has an independent risk of retreatment, which then would be additive. This assumption rests on the idea that each hematoma is an isolated disease process, which is probably not the case. Given our data, it seems that hematomas are indeed influenced by the fate of the contralateral hematoma (Fig. 3) . While ipsilateral retreatment in the unilateral surgery group (11.8%) is close to the known overall risk of retreatment for CSDH, contralateral retreatment composes a substantial part of the retreatments in the unilateral surgery group. Although the operated hematoma in the unilateral surgery group was managed successfully, the patient's condition was not since unilateral drainage led to another surgery.
Contralateral reoperation is rarely discussed in the literature. Mori et al. 10 retrospectively analyzed 500 cases of CSDH (unilateral and bilateral) and found 49 recurrences, 18 cases of which were on the contralateral side. These cases were initially classified as uCSDH, but reexamination of the preoperative CTs revealed that 14 cases demonstrated a thin SDH or effusion on the contralateral side at the primary operation. The authors deemed this phenomenon to be a causative factor for hematoma recurrence. Small hematomas or effusions, normally treated conservatively, may give rise to a growing CSDH after drainage of the contralateral hemisphere. In our study the size of the operated and nonoperated hematoma was not correlated with the site of retreatment. Hence, contralateral or ipsilateral retreatment was not predicted by the size of the operated or nonoperated hematoma. The unilateral surgical intervention seems to be the causative factor for the higher RR and is not influenced by hematoma size. This phenomenon may be explained by unilateral surgery causing a decrease in intracranial pressure, which permits expansion of the nonoperated contralateral hematoma. Unilateral drainage may also cause displacement of the brain toward the operated side, increasing the contralateral subdural space. Persistence of an enlarged subdural space creates potential for hematoma accumulation in the absence of the tamponading effect of the displaced brain.
To find twice as high an RR in the unilateral surgery group is, however, surprising, leading to the suggestion that more patients with bCSDH should be treated with bilateral drainage. However, in some cases of bCSDH, small hematomas on one side make bilateral intervention difficult and inadvisable because of the small distance to the cortex, thereby increasing the risk of damaging the brain during surgery.
The interventional effect of bilateral drainage was calculated with a number needed to treat (NNT) of 6.8 patients. Given the limited amount of additional resources required for bilateral drainage (as opposed to unilateral drainage) and the insignificant increase in related complications documented in our study, it may be beneficial to perform bilateral drainage on more patients with bCSDH. The possible advantages should be weighed against complication rates and rehospitalization. Complication rates favored the unilateral approach, although the factor did not reach statistical significance in our study. It is important, however, to recognize that complication rates for retreatment procedures are generally considered to be higher than in primary surgery. Patients with CSDH are mainly older, which makes it especially important to prevent rehospitalization. Older patients are at particular risk for loss of function in activities of daily living, 4 developing delirium, 20 and acquiring hospital-related infections 18 during hospital admittance. Rehospitalization of older patients is thereby associated with a higher risk of morbidity and mortality. The primary limitation of this study is its retrospective design; thus, there is a risk of selection bias in the 2 surgery groups (unilateral and bilateral). Given our data and personal communications with neurosurgeons in each of the participating departments, we believe that the surgeon's choice of surgical procedure was based on symptoms and hematoma size. Comorbidity does not seem to influence the choice of treatment. Randomized studies of unilateral and bilateral surgical interventions in bCSDH would overcome such a selection bias.
All patients were identified by an ICD-10 diagnosis of CSDH and validated by reviewing the medical records and CT scans for each individual. However, we may have missed some cases that were misclassified with a wrong diagnosis, although the Danish National Patient Register is considered to have good validity.
7 Nonetheless, the major strengths of our study are its inclusion of all neurosurgical departments in Denmark and the number of complete data sets, including at least 1 year of follow-up for all patients. Our findings regarding previously identified risk factors are consistent with previous studies on CSDH. This study is, to our knowledge, the first of its kind to comprise a national, consecutively sampled cohort of CSDH patients.
Conclusions
This study establishes unilateral surgery of bCSDH as an independent risk factor for retreatment. Unilateral or bilateral drainage of bCSDH is a decision made by the clinician primarily on the basis of hematoma volume and clinical symptoms. In light of our current findings, we suggest that the increased risk of retreatment from unilateral drainage should be considered in the risk assessment and decision making for surgical drainage of bCSDH.
